Patient-Centered Decision Support for Eosinophilic Esophagitis

This study is looking at how people with Eosinophilic Esophagitis (EoE), a chronic allergic inflammatory disease of the esophagus, prefer to receive and use educational materials about their treatment options. Researchers are comparing two approaches: a "General education control" where you review standard online materials, and a "Decision support tool" where you review tailored online materials. Both groups will complete surveys before and after reviewing the materials, around the time of a regular doctor's appointment. The study aims to enroll 40 participants aged 18 or older who are new EoE patients at the University of Michigan and can read English. The main goals are to see if these educational tools are practical to use and well-liked by patients.

Study design: This interventional study plans to enroll 40 participants. It compares two behavioral interventions: general education materials versus a tailored decision support tool.
What's involved: You would complete an online survey before reviewing educational materials and then a follow-up survey approximately 3 months later. These activities are timed around a standard doctor's appointment.
Compensation: Not stated in the trial record.
Follow-up: Participants will complete a follow-up survey approximately 3 months after their clinic visit. Acceptability will be measured at approximately 4 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

Patient-Centered Decision Support for Eosinophilic Esophagitis

Recruiting

NAAges 18+InterventionalHealth services

University of Michigan

~40 participants

Updated 2026-03-31 on ClinicalTrials.gov

What's tested:General education controlDecision support tool

At a glance

Recruiting sites

1 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Feasibility: measured as the proportion of eligible patients that consent to participate in the study

Measured over Recruitment period approximately 18 months

+1 more outcome measured

Conditions

Eosinophilic Esophagitis

Where it's being run

1 sites across 1 states

Michigan1

Study leadership

Joy Chang, MD, MS · PRINCIPAL_INVESTIGATOR · University of Michigan

Who to contact

Kelcie Brophy

[email protected]

734-615-0531

Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

New EoE patient evaluations ≥18 years old at University of Michigan (UM) that have an upcoming outpatient visit in a UM-gastroenterology or allergy \& immunology clinic,

Able to speak and read English.

Exclusion

Prisoners and institutionalized individuals due to logistical limitations for use of a web app and follow-up interactions in these populations.

Patients that have significant cognitive or visual impairment that limits interaction with the decision aid (DA)

Patients that are terminally ill

Patients that do not have an email address or reliable access to the internet

What this trial measures

Feasibility: measured as the proportion of eligible patients that consent to participate in the studyRecruitment period approximately 18 months
The study aims to achieve at least 20% consented for eligible patients.
Acceptability: measured on a 4-point Likert scaleApproximately 4 months
Measured on a 4-point Likert-scale (1) Very Unhelpful to (4) Very Helpful. Analyzed as high scores indicate more helpful.

Trialytics